23.05.2023 - 25.05.2023Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 am - 3:45 pm
Temi della conferenza The surge in demand for speed-to-market patient delivery of drugs is exponential, meaning that the pressure to develop new drug-development sites is now more prominent than ever before. Excitement in the field is evident: Novartis has invested in 3 new manufacturing sites, BMS is scaling up production for Breyanzi, and Thermo Fisher has opened a 300,000 ft² viral vector production site in Boston.
Speakers: Alex Oliveira, Senior Engineering Manager, ILC Dover, Brenden Alexander, Director, Day 2 Construction and Global Facilities, SmartLabs, and more.